Ongoing research programs are focused on adult and embryonic / pluripotent stem cells biology in malignancies and their therapeutic use in targeted therapies and regenerative medicine.

Our translational medicine program is expected to be highly innovative by

  • Proposing new therapeutic strategies based on stem cells and chronobiology
  • Identifying new biomarkers and cancer neo-antigens by extensive genomic studies and bioinformatics
  • Developing new technologies and methods to explore the cancer genomic landscape and monitor disease progression and treatment effects
  • Identifying targets for new combined treatment and drug discovery